The Notal Home OCT is a first-of-its-kind artificial intelligence-enabled program for monitoring neovascular Age-related Macular Degeneration (nAMD) using a home-based Optical Coherence Tomography (OCT) device, which will complement current disease monitoring strategies by providing eye care providers.

A comprehensive remote patient monitoring service that leverages innovative home-based OCT technology and AI to make reviewing patient data easy and intuitive. The patient self-operated SCANLY Home OCT device captures spectral-domain OCT images in a 10 by 10-degree area centered on the point of fixation.

2024年5月16日 · ital healthcare provider, Notal Vision, announced today that the US Food and Drug Administration (FDA) has granted De Novo authorization for its patient self-operated SCANLY® Home OCT device. Designated by the F. as a Breakthrough Device for patients suffering from wet, or neovascular, age-related macular degeneration (nvAMD), SCANLY Home OCT …

2023年3月1日 · Several home-based OCT devices are under investigation for wet AMD. The one that appears closest to FDA approval is Notal Home OCT (Notal Vision), an AI-enabled program and lightweight, spectral-domain device. 1 It uses a predetermined pattern of 88 B-scans across a 3 mm × 3 mm area at the macula, said Dr. Kim. Use.

Home (OCT) refers to a home-based system that is capable of acquiring OCT images. Its first use has been evaluated in retinal diseases, particularly AMD for the reasons discussed above. OCT images of the retina are acquired by directing the beam to the retina through the pupil of the eye.

2023年2月25日 · Notal Vision Inc. recently reported the latest data on its investigational home-based optical coherence tomography (OCT) and how the service can be used to manage wet age-related macular degeneration (AMD).

2022年3月12日 · Notal Home OCT 管线技术旨在提供患者启动的视网膜 OCT 扫描，以支持湿性年龄相关性黄斑变性 (AMD) 患者的管理，补充现有的护理治疗标准以及新兴的长效药物和给药系统.

2 天之前 · The “Home OCT Fluid Visualization Study” was a prospective, longitudinal study. Adults aged 55 years or older with a prior diagnosis of nAMD in at least one eye and best-corrected visual acuity of 20/320 or better were enrolled by their retina physician one week prior to a previously scheduled, routine clinic visit. Those who required anti ...

• Home-based OCT could optimize patient care by increasing the feasibility of prn-based treatments, expediting detection and treatment of disease progression. • Pairing this technology with AI software to analyze subretinal fluid and notify physicians of changes could reduce unnecessary clinic visits.

2024年5月5日 · Advancements in optical coherence tomography (OCT) technology, a vital tool in managing neovascular age-related macular degeneration (nAMD), have allowed the development of home-based OCT systems that patients can use to self-image on a daily basis, providing the potential to impact and transform patient care.